RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation

Wilson, Jane A. C., Prow, Natalie A., Schroder, Wayne A., Ellis, Jonathan J., Cumming, Helen E., Gearing, Linden J., Poo, Yee Suan, Taylor, Adam, Hertzog, Paul J., Di Giallonardo, Francesca, Hueston, Linda, Le Grand, Roger, Tang, Bing, Le, Thuy T., Gardner, Joy, Mahalingam, Suresh, Roques, Pierre, Bird, Phillip I. and Suhrbier, Andreas (2017) RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation. PLoS Pathogens, 13 2: . doi:10.1371/journal.ppat.1006155

Author Wilson, Jane A. C.
Prow, Natalie A.
Schroder, Wayne A.
Ellis, Jonathan J.
Cumming, Helen E.
Gearing, Linden J.
Poo, Yee Suan
Taylor, Adam
Hertzog, Paul J.
Di Giallonardo, Francesca
Hueston, Linda
Le Grand, Roger
Tang, Bing
Le, Thuy T.
Gardner, Joy
Mahalingam, Suresh
Roques, Pierre
Bird, Phillip I.
Suhrbier, Andreas
Title RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation
Journal name PLoS Pathogens   Check publisher's open access policy
ISSN 1553-7374
Publication date 2017-02-16
Sub-type Article (original research)
DOI 10.1371/journal.ppat.1006155
Open Access Status DOI
Volume 13
Issue 2
Total pages 32
Place of publication San Francisco, CA, United States
Publisher Public Library of Science
Collection year 2018
Language eng
Formatted abstract
Chikungunya virus (CHIKV) is an arthritogenic alphavirus causing epidemics of acute and chronic arthritic disease. Herein we describe a comprehensive RNA-Seq analysis of feet and lymph nodes at peak viraemia (day 2 post infection), acute arthritis (day 7) and chronic disease (day 30) in the CHIKV adult wild-type mouse model. Genes previously shown to be up-regulated in CHIKV patients were also up-regulated in the mouse model. CHIKV sequence information was also obtained with up to ≈8% of the reads mapping to the viral genome; however, no adaptive viral genome changes were apparent. Although day 2, 7 and 30 represent distinct stages of infection and disease, there was a pronounced overlap in up-regulated host genes and pathways. Type I interferon response genes (IRGs) represented up to ≈50% of up-regulated genes, even after loss of type I interferon induction on days 7 and 30. Bioinformatic analyses suggested a number of interferon response factors were primarily responsible for maintaining type I IRG induction. A group of genes prominent in the RNA-Seq analysis and hitherto unexplored in viral arthropathies were granzymes A, B and K. Granzyme A-/- and to a lesser extent granzyme K-/-, but not granzyme B-/-, mice showed a pronounced reduction in foot swelling and arthritis, with analysis of granzyme A-/- mice showing no reductions in viral loads but reduced NK and T cell infiltrates post CHIKV infection. Treatment with Serpinb6b, a granzyme A inhibitor, also reduced arthritic inflammation in wild-type mice. In non-human primates circulating granzyme A levels were elevated after CHIKV infection, with the increase correlating with viral load. Elevated granzyme A levels were also seen in a small cohort of human CHIKV patients. Taken together these results suggest granzyme A is an important driver of arthritic inflammation and a potential target for therapy.

Trial Registration: ClinicalTrials.gov NCT00281294
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: HERDC Pre-Audit
School of Chemistry and Molecular Biosciences
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Tue, 14 Mar 2017, 00:24:17 EST by System User on behalf of Learning and Research Services (UQ Library)